Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993 Aug;34(8):1025–1031. doi: 10.1136/gut.34.8.1025

Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.

W Inauen 1, C Emde 1, B Weber 1, D Armstrong 1, H U Bettschen 1, T Huber 1, U Scheurer 1, A L Blum 1, F Halter 1, H S Merki 1
PMCID: PMC1374347  PMID: 8174947

Abstract

The effect of ranitidine and cisapride on acid reflux and oesophageal motility was investigated in 18 patients with endoscopically verified erosive reflux oesophagitis. Each patient was treated with placebo, ranitidine (150 mg twice daily), and ranitidine (150 mg twice daily) plus cisapride (20 mg twice daily) in a double blind, double dummy, within subject, three way cross over design. Oesophageal acidity and motility were monitored under ambulatory conditions for 24 hours on the fourth day of treatment, after a wash out period of 10 days during which patients received only antacids for relief of symptoms. Acid reflux was monitored by a pH electrode located 5 cm above the lower oesophageal sphincter. Intraoesophageal pressure was simultaneously recorded from four transducers placed 20, 15, 10, and 5 cm above the lower oesophageal sphincter. Upright reflux was three times higher than supine reflux (median (range) 13.3 (3.7-35.0)% v 3.7 (0-37.6)% of the time with pH < 4.0, p < 0.01, n = 18). Compared with placebo, ranitidine decreased total reflux (from 10.0 (3.2-32.6)% to 6.4 (1.2-22.9)%, p < 0.01), upright reflux (p < 0.05), supine reflux (p < 0.001), and postprandial reflux (p < 0.01), but did not affect oesophageal motility. The combination of ranitidine with cisapride further diminished the acid reflux found with ranitidine--that is, cisapride led to an additional reduction of total reflux (from 6.4 (1.2-22.9)% to 3.7 (1.0-12.7)%, p < 0.01), supine reflux (p < 0.05), and postprandial reflux (p < 0.05). Cisapride also reduced both the number (p<0.01) and duration (p<0.05) of reflux episodes and significantly increased amplitude, duration, and propagation velocity of oesophageal contractions (p<0.05) but did not affect the number of contractions. The findings show that the 30% reduction of oesophageal acid exposure achieved by a conventional dose of ranitidine (150 mg twice daily) can be improved to more than 60% by combination with cisapride (20 mg twice daily). The cisapride induced increase in oesophageal contractile force and propagation velocity seems to enhance the clearance of gastro-oesophageal reflux. Combination of a histamine H2 receptor antagonist with a prokinetic agent may therefore provide an alternative treatment for reflux oesophagitis.

Full text

PDF
1025

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong D., Emde C., Bumm R., Castiglione F., Cilluffo T., Blum A. L. Twenty-four-hour pattern of esophageal motility in asymptomatic volunteers. Dig Dis Sci. 1990 Oct;35(10):1190–1197. doi: 10.1007/BF01536406. [DOI] [PubMed] [Google Scholar]
  2. Baldi F., Bianchi Porro G., Dobrilla G., Iascone C., Lobello R., Marzio L., Sabbatini F., Tittobello A., Verme G. Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial. J Clin Gastroenterol. 1988 Dec;10(6):614–618. doi: 10.1097/00004836-198812000-00007. [DOI] [PubMed] [Google Scholar]
  3. Baldi F., Ferrarini F., Balestra R., Borioni D., Longanesi A., Miglioli M., Barbara L. Oesophageal motor events at the occurrence of acid reflux and during endogenous acid exposure in healthy subjects and in patients with oesophagitis. Gut. 1985 Apr;26(4):336–341. doi: 10.1136/gut.26.4.336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baldi F., Ferrarini F., Longanesi A., Angeloni M., Ragazzini M., Miglioli M., Barbara L. Oesophageal function before, during, and after healing of erosive oesophagitis. Gut. 1988 Feb;29(2):157–160. doi: 10.1136/gut.29.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Behar J., Ramsby G. Gastric emptying and antral motility in reflux esophagitis. Effect of oral metoclopramide. Gastroenterology. 1978 Feb;74(2 Pt 1):253–256. [PubMed] [Google Scholar]
  6. Ceccatelli P., Janssens J., Vantrappen G., Cucchiara S. Cisapride restores the decreased lower oesophageal sphincter pressure in reflux patients. Gut. 1988 May;29(5):631–635. doi: 10.1136/gut.29.5.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Corazziari E., Bontempo I., Anzini F. Effects of cisapride on distal esophageal motility in humans. Dig Dis Sci. 1989 Oct;34(10):1600–1605. doi: 10.1007/BF01537117. [DOI] [PubMed] [Google Scholar]
  8. Dent J., Dodds W. J., Friedman R. H., Sekiguchi T., Hogan W. J., Arndorfer R. C., Petrie D. J. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest. 1980 Feb;65(2):256–267. doi: 10.1172/JCI109667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dodds W. J., Dent J., Hogan W. J., Helm J. F., Hauser R., Patel G. K., Egide M. S. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med. 1982 Dec 16;307(25):1547–1552. doi: 10.1056/NEJM198212163072503. [DOI] [PubMed] [Google Scholar]
  10. Dodds W. J., Hogan W. J., Helm J. F., Dent J. Pathogenesis of reflux esophagitis. Gastroenterology. 1981 Aug;81(2):376–394. [PubMed] [Google Scholar]
  11. Emde C., Armstrong D., Castiglione F., Cilluffo T., Riecken E. O., Blum A. L. Reproducibility of long-term ambulatory esophageal combined pH/manometry. Gastroenterology. 1991 Jun;100(6):1630–1637. doi: 10.1016/0016-5085(91)90662-5. [DOI] [PubMed] [Google Scholar]
  12. Eriksen C. A., Sadek S. A., Cranford C., Sutton D., Kennedy N., Cuschieri A. Reflux oesophagitis and oesophageal transit: evidence for a primary oesophageal motor disorder. Gut. 1988 Apr;29(4):448–452. doi: 10.1136/gut.29.4.448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Galmiche J. P., Fraitag B., Filoche B., Evreux M., Vitaux J., Zeitoun P., Fournet J., Soule J. C. Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis. Dig Dis Sci. 1990 May;35(5):649–655. doi: 10.1007/BF01540415. [DOI] [PubMed] [Google Scholar]
  14. Gilbert R. J., Dodds W. J., Kahrilas P. J., Hogan W. J., Lipman S. Effect of cisapride, a new prokinetic agent, on esophageal motor function. Dig Dis Sci. 1987 Dec;32(12):1331–1336. doi: 10.1007/BF01296657. [DOI] [PubMed] [Google Scholar]
  15. Gill R. C., Bowes K. L., Murphy P. D., Kingma Y. J. Esophageal motor abnormalities in gastroesophageal reflux and the effects of fundoplication. Gastroenterology. 1986 Aug;91(2):364–369. doi: 10.1016/0016-5085(86)90570-6. [DOI] [PubMed] [Google Scholar]
  16. Havelund T., Laursen L. S., Skoubo-Kristensen E., Andersen B. N., Pedersen S. A., Jensen K. B., Fenger C., Hanberg-Sørensen F., Lauritsen K. Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial. Br Med J (Clin Res Ed) 1988 Jan 9;296(6615):89–92. doi: 10.1136/bmj.296.6615.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hillemeier A. C., Grill B. B., McCallum R., Gryboski J. Esophageal and gastric motor abnormalities in gastroesophageal reflux during infancy. Gastroenterology. 1983 Apr;84(4):741–746. [PubMed] [Google Scholar]
  18. Holloway R. H., Downton J., Mitchell B., Dent J. Effect of cisapride on postprandial gastro-oesophageal reflux. Gut. 1989 Sep;30(9):1187–1193. doi: 10.1136/gut.30.9.1187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Holloway R. H., Hongo M., Berger K., McCallum R. W. Gastric distention: a mechanism for postprandial gastroesophageal reflux. Gastroenterology. 1985 Oct;89(4):779–784. doi: 10.1016/0016-5085(85)90572-4. [DOI] [PubMed] [Google Scholar]
  20. Janisch H. D., Hüttemann W., Bouzo M. H. Cisapride versus ranitidine in the treatment of reflux esophagitis. Hepatogastroenterology. 1988 Jun;35(3):125–127. [PubMed] [Google Scholar]
  21. Johansson K. E., Tibbling L. Gastric secretion and reflux pattern in reflux oesophagitis before and during ranitidine treatment. Scand J Gastroenterol. 1986 May;21(4):487–492. doi: 10.3109/00365528609015167. [DOI] [PubMed] [Google Scholar]
  22. Johnson L. F., Demeester T. R. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol. 1974 Oct;62(4):325–332. [PubMed] [Google Scholar]
  23. Johnsson F., Joelsson B. Reproducibility of ambulatory oesophageal pH monitoring. Gut. 1988 Jul;29(7):886–889. doi: 10.1136/gut.29.7.886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kahrilas P. J., Dodds W. J., Hogan W. J., Kern M., Arndorfer R. C., Reece A. Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology. 1986 Oct;91(4):897–904. doi: 10.1016/0016-5085(86)90692-x. [DOI] [PubMed] [Google Scholar]
  25. Keshavarzian A., Bushnell D. L., Sontag S., Yegelwel E. J., Smid K. Gastric emptying in patients with severe reflux esophagitis. Am J Gastroenterol. 1991 Jun;86(6):738–742. [PubMed] [Google Scholar]
  26. Klinkenberg-Knol E. C., Festen H. P., Meuwissen S. G. The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis. Aliment Pharmacol Ther. 1988 Jun;2(3):221–227. doi: 10.1111/j.1365-2036.1988.tb00691.x. [DOI] [PubMed] [Google Scholar]
  27. Koelz H. R., Birchler R., Bretholz A., Bron B., Capitaine Y., Delmore G., Fehr H. F., Fumagalli I., Gehrig J., Gonvers J. J. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology. 1986 Nov;91(5):1198–1205. doi: 10.1016/s0016-5085(86)80017-8. [DOI] [PubMed] [Google Scholar]
  28. Lepoutre L., Van der Spek P., Vanderlinden I., Bollen J., Laukens P. Healing of grade-II and III oesophagitis through motility stimulation with cisapride. Digestion. 1990;45(2):109–114. doi: 10.1159/000200231. [DOI] [PubMed] [Google Scholar]
  29. Lind T., Cederberg C., Idström J. P., Lönroth H., Olbe L., Lundell L. 24-hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis. Scand J Gastroenterol. 1991 Jun;26(6):620–626. doi: 10.3109/00365529109043636. [DOI] [PubMed] [Google Scholar]
  30. Lundell L., Backman L., Ekström P., Enander L. K., Falkmer S., Fausa O., Grimelius L., Havu N., Lind T., Lönroth H. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol. 1991 Mar;26(3):248–256. doi: 10.3109/00365529109025038. [DOI] [PubMed] [Google Scholar]
  31. Maddern G. J., Jamieson G. G., Myers J. C., Collins P. J. Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease. Gut. 1991 May;32(5):470–474. doi: 10.1136/gut.32.5.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mahachai V., Walker K., Thomson A. B., Zuk L., Kirdeikis P., Fisher D., Brunet K. Comparison of cimetidine and ranitidine on 24-hour intragastric acidity and serum gastrin profile in patients with esophagitis. Dig Dis Sci. 1985 Apr;30(4):321–328. doi: 10.1007/BF01403840. [DOI] [PubMed] [Google Scholar]
  33. Maleev A., Mendizova A., Popov P., Vlahov V., Dimitrov B., Mihova A., Crowe J., Silveira J., Thomson A., Routhier G. Cisapride and cimetidine in the treatment of erosive esophagitis. Hepatogastroenterology. 1990 Aug;37(4):403–407. [PubMed] [Google Scholar]
  34. McCallum R. W., Berkowitz D. M., Lerner E. Gastric emptying in patients with gastroesophageal reflux. Gastroenterology. 1981 Feb;80(2):285–291. [PubMed] [Google Scholar]
  35. McCallum R. W., Fink S. M., Lerner E., Berkowitz D. M. Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients. Gastroenterology. 1983 Jun;84(6):1573–1577. [PubMed] [Google Scholar]
  36. Richter J. E., Wu W. C., Johns D. N., Blackwell J. N., Nelson J. L., 3rd, Castell J. A., Castell D. O. Esophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of "abnormal" contractions. Dig Dis Sci. 1987 Jun;32(6):583–592. doi: 10.1007/BF01296157. [DOI] [PubMed] [Google Scholar]
  37. Shay S. S., Eggli D., McDonald C., Johnson L. F. Gastric emptying of solid food in patients with gastroesophageal reflux. Gastroenterology. 1987 Feb;92(2):459–465. doi: 10.1016/0016-5085(87)90142-9. [DOI] [PubMed] [Google Scholar]
  38. Sikiric P., Rotkvic I., Mise S., Petek M., Rucman R., Seiwerth S., Zjacic-Rotkvic V., Duvnjak M., Jagic V., Suchanek E. Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine. Dig Dis Sci. 1991 Jul;36(7):905–910. doi: 10.1007/BF01297139. [DOI] [PubMed] [Google Scholar]
  39. Smout A. J., Breedijk M., van der Zouw C., Akkermans L. M. Physiological gastroesophageal reflux and esophageal motor activity studied with a new system for 24-hour recording and automated analysis. Dig Dis Sci. 1989 Mar;34(3):372–378. doi: 10.1007/BF01536258. [DOI] [PubMed] [Google Scholar]
  40. Toussaint J., Gossuin A., Deruyttere M., Hublé F., Devis G. Healing and prevention of relapse of reflux oesophagitis by cisapride. Gut. 1991 Nov;32(11):1280–1285. doi: 10.1136/gut.32.11.1280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Tytgat G. N., Nio C. Y., Schotborgh R. H. Reflux esophagitis. Scand J Gastroenterol Suppl. 1990;175:1–12. doi: 10.3109/00365529009093121. [DOI] [PubMed] [Google Scholar]
  42. Verlinden M. Review article: a role for gastrointestinal prokinetic agents in the treatment of reflux oesophagitis? Aliment Pharmacol Ther. 1989 Apr;3(2):113–131. doi: 10.1111/j.1365-2036.1989.tb00197.x. [DOI] [PubMed] [Google Scholar]
  43. Wiener G. J., Morgan T. M., Copper J. B., Wu W. C., Castell D. O., Sinclair J. W., Richter J. E. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci. 1988 Sep;33(9):1127–1133. doi: 10.1007/BF01535789. [DOI] [PubMed] [Google Scholar]
  44. de Caestecker J. S., Blackwell J. N., Pryde A., Heading R. C. Daytime gastro-oesophageal reflux is important in oesophagitis. Gut. 1987 May;28(5):519–526. doi: 10.1136/gut.28.5.519. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES